Eosinophilic pneumonia associated with natalizumab in a patient with multiple sclerosis: A case report and literature review

5Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We herein report the case of a 39-year-old Japanese female with eosinophilic pneumonia associated with natalizumab. The patient with bronchial asthma had multiple sclerosis and was treated using natalizumab. The patient was referred to our department because of a persistent cough. A chest computed tomography (CT) scan revealed bilateral patchy consolidation surrounded by ground-glass opacity. A bronchoalveolar lavage (BAL) was performed. Eosinophil levels in the BAL fluid were increased and the patient was consequently diagnosed as eosinophilic pneumonia associated with natalizumab. Therefore, natalizumab treatment was discontinued. Subsequent chest CT findings showed a remarkable improvement without any treatment.

Cite

CITATION STYLE

APA

Yasuda, Y., Nagano, T., Tachihara, M., Chihara, N., Umezawa, K., Katsurada, N., … Nishimura, Y. (2019). Eosinophilic pneumonia associated with natalizumab in a patient with multiple sclerosis: A case report and literature review. Therapeutics and Clinical Risk Management, 15, 1283–1289. https://doi.org/10.2147/TCRM.S225832

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free